SAN DIEGO—Matthew Singleton, a director at Viking Therapeutics, Inc. (NASDAQ:VKTX), recently executed a significant stock sale, according to a filing with the Securities and... ByInvesting.com ...
Zacks.com on MSN11h
Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateKey Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...
Be Nutty: “Nuts are an excellent choice for controlling inflammation,” say experts at the University of North Carolina. “They ...
HOUSTON--Conexus MedStaff partners with Taimaka in support of providing critical malnutrition care to children in Gombe state ...
Hartford HealthCare is partnering with the American School for the Deaf to reduce communication barriers for deaf and hard-of ...
TV, the nation's leading Spanish-language public broadcaster, is proud to announce a partnership with South Florida PBS to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback